The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Reversible Self-Association Increases the Viscosity of a Concentrated Monoclonal Antibody in Aqueous Solution
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schuck, P. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76713-0 · Cited by 3,868
Proteins: Structures and Molecular Properties
Creighton, T. E. (1986) · Medical Entomology and Zoology · Cited by 2,645
Arky, R. A. (1994) · Cited by 2,632
Macromolecular Crowding: Biochemical, Biophysical, and Physiological Consequences
Zimmerman, S. B., & Minton, A. P. (1993) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.bb.22.060193.000331 · Cited by 1,513
Stabilization of protein structure by sugars
Arakawa, T., & Timasheff, S. N. (1982) · Biochemistry · doi:10.1021/bi00268a033 · Cited by 1,083
The stabilization of proteins by osmolytes
Arakawa, T., & Timasheff, S. N. (1985) · Biophysical Journal · doi:10.1016/s0006-3495(85)83932-1 · Cited by 1,020
Challenges in the development of high protein concentration formulations
Shire, S. J., Shahrokh, Z., & Liu, J. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20079 · Cited by 882
Self-citationProteins: Structures and molecular properties
Freedman, R. B. (1985) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(85)90239-7 · Cited by 664
Challenges in the Development of High Protein Concentration Formulations
Shire, S. J., Shahrokh, Z., & Liu, J. (2010) · Current Trends in Monoclonal Antibody Development and Manufacturing · doi:10.1007/978-0-387-76643-0_9 · Cited by 657
Self-citationPERKINS, S. J. (1986) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1986.tb09653.x · Cited by 582
Cited by
Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies
Mitragotri, S., Burke, P. A., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4363 · Cited by 1,702
Antibody Structure, Instability, and Formulation
Wang, W., Singh, S., Zeng, D. L., King, K., & Nema, S. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20727 · Cited by 941
Protein aggregation: Pathways, induction factors and analysis
Mahler, H.-C., Friess, W., Grauschopf, U., & Kiese, S. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21566 · Cited by 901
Protein aggregation and bioprocessing
Cromwell, M. E. M., Hilario, E., & Jacobson, F. (2006) · The AAPS Journal · doi:10.1208/aapsj080366 · Cited by 753
Kamerzell, T. J., Esfandiary, R., Joshi, S. B., Middaugh, C. R., & Volkin, D. B. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.07.006 · Cited by 510
Aggregates in monoclonal antibody manufacturing processes
Vázquez‐Rey, M., & Lang, D. A. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.23155 · Cited by 479
Physicochemical Stability of Monoclonal Antibodies: A Review
Le Basle, Y., Chennell, P., Tokhadze, N., Astier, A., & Sautou, V. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.08.009 · Cited by 429
Connolly, B. D., Petry, C., Yadav, S., Demeule, B., Ciaccio, N., Moore, J. M. R., Shire, S. J., & Gokarn, Y. R. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2012.04.047 · Cited by 340
Self-citationFormulation and manufacturability of biologics
Shire, S. J. (2009) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2009.10.006 · Cited by 330
Self-citationKanai, S., Liu, J., Patapoff, T. W., & Shire, S. J. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21322 · Cited by 304
Self-citationYadav, S., Laue, T. M., Kalonia, D. S., Singh, S. N., & Shire, S. J. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200566k · Cited by 280
Self-citationA review of Formulations of Commercially Available Antibodies
Strickley, R. G., & Lambert, W. J. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.03.017 · Cited by 271
Structure, heterogeneity and developability assessment of therapeutic antibodies
Xu, Y., Wang, D., Mason, B., Rossomando, T., Li, N., Liu, D., Cheung, J. K., Xu, W., Raghava, S., Katiyar, A., et al. (2019) · mAbs · doi:10.1080/19420862.2018.1553476 · Cited by 264
Factors Affecting the Viscosity in High Concentration Solutions of Different Monoclonal Antibodies
Yadav, S., Shire, S. J., & Kalonia, D. S. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22190 · Cited by 255
Self-citationSharma, V. K., Patapoff, T. W., Kabakoff, B., Pai, S., Hilario, E., Zhang, B., Li, C., Borisov, O., Kelley, R. F., Chorny, I., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421779112 · Cited by 254
Specific interactions in high concentration antibody solutions resulting in high viscosity
Yadav, S., Liu, J., Shire, S. J., & Kalonia, D. S. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21898 · Cited by 252
Self-citationLai, P.-K., Gallegos, A., Mody, N., Sathish, H. A., & Trout, B. L. (2022) · mAbs · doi:10.1080/19420862.2022.2026208 · Cited by 103
Doughty, D. V., Clawson, C. Z., Lambert, W., & Subramony, J. A. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.04.009 · Cited by 74
Rolinger, L., Rüdt, M., Diehm, J., Chow-Hubbertz, J., Heitmann, M., Schleper, S., & Hubbuch, J. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-019-02318-8 · Cited by 46
Nanoplasmonic Avidity‐Based Detection and Quantification of IgG Aggregates
Tran, T., Martinsson, E., Vargas, S., Lundström, I., Mandenius, C.-F., & Aili, D. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c03446 · Cited by 8
Metadata
- Authors
- Liu, J., Nguyen, M. D. H., Andya, J. D., & Shire, S. J.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2005-09
- Volume
- 94
- Issue
- 9
- Pages
- 1928-1940
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W2076100371
- Cited by
- 436
- References
- 25
- FWCI
- 3.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.